Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Telmisartan RM

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.

    Virtual Booth

    Contact Supplier

    Menu

    TWYNSTA-1

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 149Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    George Medicine, Azurity Pharma Ink Deal to Market WIDAPLIK in US
    George Medicine, Azurity Pharma Ink Deal to Market WIDAPLIK in US

    21 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/21/3118577/0/en/George-Medicines-signs-exclusive-licensing-agreement-with-Azurity-Pharmaceuticals-to-commercialize-WIDAPLIK-telmisartan-amlodipine-and-indapamide-tablets-in-the-US.html

    GLOBENEWSWIRE
    21 Jul 2025
    Share Share
    Veristat Congratulate George Medicine on FDA Approval of Widaplik
    Veristat Congratulate George Medicine on FDA Approval of Widaplik

    16 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250616203834/en/Veristat-Congratulates-George-Medicines-on-FDA-Approval-of-WIDAPLIK

    BUSINESSWIRE
    16 Jun 2025
    Share Share
    George Medicines announces FDA approval of Widaplik
    George Medicines announces FDA approval of Widaplik

    09 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/09/3095734/0/en/George-Medicines-announces-FDA-approval-of-WIDAPLIK-telmisartan-amlodipine-and-indapamide-a-new-single-pill-combination-treatment-for-hypertension-in-adults-including-initial-treat.html

    GLOBENEWSWIRE
    09 Jun 2025
    Share Share
    Maharashtra FDA begins probe stickering & mislabelling on Glenmark's drug Telma
    Maharashtra FDA begins probe stickering & mislabelling on Glenmark's drug Telma

    05 Apr 2024

    // DERUG CONTROL

    https://www.drugscontrol.org/news-detail.php?newsid=39001

    DERUG CONTROL
    05 Apr 2024
    Share Share
    Enforcement Report - Week of August 17, 2022
    Enforcement Report - Week of August 17, 2022

    17 Aug 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-17-2022-1660735823.pdf

    FDA
    17 Aug 2022
    Share Share
    Telmisartan combination trial studies combination anti-hypertensive drug therapy
    Telmisartan combination trial studies combination anti-hypertensive drug therapy

    08 Feb 2022

    // EXPRESS PHARMA

    https://www.expresspharma.in/telmisartan-combination-trial-studies-combination-anti-hypertensive-drug-therapy-to-achieve-new-guidelines-of-bp-level/

    EXPRESS PHARMA
    08 Feb 2022
    Share Share